Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Primary Prevention|December 3, 2011
Cost-effectiveness of childcare discounts on parent participation in preventive parent training in low-income communitiesDeborah Gross, Tricia Johnson, Alison Ridge, et al.Journal of Pediatrics. Clinical Practice|April 30, 2026
Age of Entry into Early Intervention: Influence of the COVID-19 Pandemic, Telehealth, and Other FactorsLauren M Little, Sheerah Neal Keith, Anna Wallisch, et al.Medical Care|March 22, 2022
Racial and Ethnic Differences in Hospital Admissions of Emergency Department COVID-19 PatientsJoshua Longcoy, Rahul Patwari, Scott Hasler, et al.Research in Nursing & Health|September 12, 2022
Effects of the COVID-19 pandemic on recruitment for the working women walking programManju Daniel, Susan W Buchholz, Michael Schoeny, et al.Contemporary Clinical Trials|July 22, 2018
Steps to Effective Problem-Solving in group homesSarah H Ailey, Arlene M Miller, Olimpia Paun, et al.Journal of Racial and Ethnic Health Disparities|May 16, 2023
The Impact of Language on Hospital Outcomes for COVID-19 Patients: A Study of Non-English Speaking Hispanic PatientsSusan Lopez, Joshua Longcoy, Elizabeth Avery, et al.Journal of Clinical Microbiology|November 8, 2019
Prospective Evaluation of Molecular Assays for Diagnosis of VaginitisSandra S Richter, Joshua Otiso, Oluwatosin J Goje, et al.Contemporary Clinical Trials Communications|May 9, 2018
Design of a lifestyle intervention to slow menopause-related progression of intra-abdominal adipose tissue in women: The Women in the Southside Health and Fitness (WISHFIT) studySheila A Dugan, Brittney Lange-Maia, Kelly Karavolos, et al.Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptorGregori J Morriello, Gary Chicchi, Tricia Johnson, et al.Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonistsGregori J Morriello, Sander G Mills, Tricia Johnson, et al.Pageof 4